These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [Abstract] [Full Text] [Related]
3. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Expert Group, German Association for the Control of Virus Diseases and Paul-Ehrlich Society of Germany. J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262 [Abstract] [Full Text] [Related]
4. Influenza: evolving strategies in treatment and prevention. Lynch JP, Walsh EE. Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769 [Abstract] [Full Text] [Related]
5. Antivirals and influenza: frequency of resistance. Monto AS. Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569 [Abstract] [Full Text] [Related]
6. Antiviral management of seasonal and pandemic influenza. Hayden FG, Pavia AT. J Infect Dis; 2006 Nov 01; 194 Suppl 2():S119-26. PubMed ID: 17163384 [Abstract] [Full Text] [Related]
10. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2006 Jan 20; 55(2):44-6. PubMed ID: 16424859 [Abstract] [Full Text] [Related]
12. Advances in the prophylaxis and treatment of influenza illness. Based on a presentation by Frederick G. Hayden, MD. Am J Manag Care; 2000 Mar 20; 6(5 Suppl):S247-54. PubMed ID: 10977471 [Abstract] [Full Text] [Related]
13. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]. de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD. Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):73-9. PubMed ID: 14753128 [Abstract] [Full Text] [Related]
14. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Tominack RL, Hayden FG. Infect Dis Clin North Am; 1987 Jun 10; 1(2):459-78. PubMed ID: 3332798 [Abstract] [Full Text] [Related]
15. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 Sep 11; 58(35):969-72. PubMed ID: 19745803 [Abstract] [Full Text] [Related]
16. [Neuraminidase inhibitors in prophylaxis and treatment of influenza]. Nitsch-Osuch A, Brydak LB, Wardyn AK. Pol Merkur Lekarski; 2008 Jul 11; 25(145):67-73. PubMed ID: 18839619 [Abstract] [Full Text] [Related]
17. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. Uhnoo I, Linde A. Lakartidningen; 2008 Jul 11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704 [Abstract] [Full Text] [Related]
18. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Pediatr Infect Dis J; 2007 Dec 11; 26(12):1089-93. PubMed ID: 18043443 [Abstract] [Full Text] [Related]